87
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Hexamethylmelamine and Low or Moderate Dose Cisplatin With or Without Pyridoxine for Treatment of Advanced Ovarian Carcinoma: A Study of the Eastern Cooperative Oncology Group

Original Article

, , , , , , , , & show all
Pages 1-9 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Acsa Lima Marinho Fonseca de Mello, Karolynne Rodrigues de Melo, André Luiz Moreira Domingues de Sousa, Pedro José Rolim Neto & Rosali Maria Ferreira da Silva. (2020) Product indiscriminate use of vitamin risks: A review. Critical Reviews in Food Science and Nutrition 60:12, pages 2067-2082.
Read now
Taro Iguchi, Manabu Nishikawa, BaoJun Chang, Osuke Muroya, Eisuke F sato, Tatsuya Nakatani & Masayasu Inoue. (2004) Edaravone Inhibits Acute Renal Injury and Cyst Formation in Cisplatin-Treated Rat Kidney. Free Radical Research 38:4, pages 333-341.
Read now

Articles from other publishers (47)

Diana Molinares, Sara Kurtevski & Yingrong Zhu. (2023) Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments. Current Oncology Reports 25:11, pages 1227-1235.
Crossref
Seohyuk Lee, Chao Ma, Qian Shi, Pankaj Kumar, Felix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Lewis, Benjamin Tan, Richard M. Goldberg, Alan Venook, Charles Blanke, Eileen M. O'Reilly, Anthony F. Shields & Jeffrey A. Meyerhardt. (2023) Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. Journal of Clinical Oncology 41:5, pages 1079-1091.
Crossref
Francesco D’Egidio, Giorgia Lombardozzi, Housem E. Kacem Ben Haj M’Barek, Giada Mastroiacovo, Margherita Alfonsetti & Annamaria Cimini. (2022) The Influence of Dietary Supplementations on Neuropathic Pain. Life 12:8, pages 1125.
Crossref
Beata Szefler, Przemysław Czeleń, Stefan Kruszewski, Agnieszka Siomek-Górecka & Przemysław Krawczyk. (2022) The assessment of physicochemical properties of Cisplatin complexes with purines and vitamins B group. Journal of Molecular Graphics and Modelling 113, pages 108144.
Crossref
Clemens P. J. G. Wolf, Tobias Rachow, Thomas Ernst, Andreas Hochhaus, Bijan Zomorodbakhsch, Susan Foller, Matthias Rengsberger, Michael Hartmann & Jutta Huebner. (2021) Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. Journal of Cancer Research and Clinical Oncology 148:5, pages 1123-1135.
Crossref
André Nunes Volpini, Igor José de Souza Marques & Iago Dillion Lima Cavalcanti. (2022) Neurotoxicity of Cisplatin as Monotherapy or Combined Chemotherapy in Cancer Treatment. Clinical Cancer Drugs 9:1.
Crossref
Marco Cascella, Maria Rosaria Muzio, Sabrina Bimonte & Arturo Cuomo. 2022. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals 1222 1244 .
Eiman Y. Ibrahim & Barbara E. Ehrlich. (2020) Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Critical Reviews in Oncology/Hematology 145, pages 102831.
Crossref
Beata Szefler, Przemysław Czeleń, Adam Szczepanik & Piotr Cysewski. (2019) Does the Affinity of Cisplatin to B-Vitamins Impair the Therapeutic Effect in the Case of Patients with Lung Cancer-consuming Carrot or Beet Juice?. Anti-Cancer Agents in Medicinal Chemistry 19:14, pages 1775-1783.
Crossref
Norma Ybarra & Jan Seuntjens. (2019) Radio-selective effects of a natural occurring muscle-derived dipeptide in A549 and normal cell lines. Scientific Reports 9:1.
Crossref
Primandono Perbowo, Brahmana Askandar, Ratna Soebady & Ahcmad Bashory. (2019) The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients. Pain medicine 4:2, pages 41-52.
Crossref
Beata Szefler & Przemysław Czeleń. (2019) Docking of Cisplatin on Fullerene Derivatives and Some Cube Rhombellane Functionalized Homeomorphs. Symmetry 11:7, pages 874.
Crossref
Marta Maschio, Alessia Zarabla, Andrea Maialetti, Francesco Marchesi, Diana Giannarelli, Svitlana Gumenyuk, Francesco Pisani, Daniela Renzi, Edvina Galiè & Andrea Mengarelli. (2019) The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma. Integrative Cancer Therapies 18, pages 153473541988858.
Crossref
Marta Maschio, Alessia Zarabla, Andrea Maialetti, Francesco Marchesi, Diana Giannarelli, Svitlana Gumenyuk, Francesco Pisani, Daniela Renzi, Edvina Galiè & Andrea Mengarelli. (2018) Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data. Integrative Cancer Therapies 17:4, pages 1115-1124.
Crossref
Kanchanlata Singh, Mustansir Bhori, Yasar Arfat Kasu, Ganapathi Bhat & Thankamani Marar. (2018) Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity. Saudi Pharmaceutical Journal 26:2, pages 177-190.
Crossref
Eric L. Eisenhauer, Ritu Salani & Larry J. Copeland. 2018. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology 253 289.e14 .
Janet Schloss & Maree Colosimo. (2017) B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy. Current Oncology Reports 19:12.
Crossref
Marco Cascella & Maria Rosaria Muzio. (2017) Pharmacological Approaches and Natural Products for Prevention of Chemotherapy-Induced Peripheral Neuropathy - A Review. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 6, pages 47-53.
Crossref
T. Alexa-Stratulat, A. Luca, M. Bădescu, C.-R. Bohotin & I.D. Alexa. 2017. Nutritional Modulators of Pain in the Aging Population. Nutritional Modulators of Pain in the Aging Population 9 33 .
. 2016. Gynäkologische Tumoren. Gynäkologische Tumoren 281 315 .
Marco Cascella, Arturo Cuomo & Daniela ViscardiMarco Cascella, Arturo Cuomo & Daniela Viscardi. 2016. Features and Management of the Pelvic Cancer Pain. Features and Management of the Pelvic Cancer Pain 25 62 .
Gyeongyeon Hong, Jennifer White, Lihong Zhong & Linda E. Carlson. (2015) Survey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers. Integrative Cancer Therapies 14:4, pages 305-317.
Crossref
Toshiaki Nakayama. (2014) Management of Side Effects and Education of Patients in Colorectal Cancer. Nippon Daicho Komonbyo Gakkai Zasshi 67:10, pages 919-927.
Crossref
Janet M. Schloss, Maree Colosimo, Caroline Airey, Paul P. Masci, Anthony W. Linnane & Luis Vitetta. (2013) Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review. Clinical Nutrition 32:6, pages 888-893.
Crossref
Min Chen, Lingli Zhang, Qian Wang & Jiantong Shen. (2013) Pyridoxine for Prevention of Hand-Foot Syndrome Caused by Chemotherapy: A Systematic Review. PLoS ONE 8:8, pages e72245.
Crossref
Roman Mezencev, Lijuan Wang & John F McDonald. (2012) Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening. Journal of Ovarian Research 5:1.
Crossref
P G Corrie, R Bulusu, C B Wilson, G Armstrong, S Bond, R Hardy, S Lao-Sirieix, D Parashar, A Ahmad, F Daniel, M Hill, G Wilson, C Blesing, A M Moody, K McAdam & M Osborne. (2012) A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications. British Journal of Cancer 107:4, pages 585-587.
Crossref
Eric L. Eisenhauer, Ritu Salani & Larry J. Copeland. 2012. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology 285 328.e12 .
Madhu B. Garg & Stephen P. Ackland. (2010) Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect. Cancer Chemotherapy and Pharmacology 67:4, pages 963-966.
Crossref
T CHALERMCHAI, K TANTIPHLACHIVA, H SUWANRUSME, N VORAVUD & V SRIURANPONG. (2010) Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia. Asia-Pacific Journal of Clinical Oncology 6:3, pages 155-160.
Crossref
Yoon-Koo KangSung Sook LeeDok Hyun YoonSo Young LeeYoung Ju ChunMin Sun KimMin-Hee RyuHeung-Moon ChangJae-Lyun LeeTae Won Kim. (2010) Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Journal of Clinical Oncology 28:24, pages 3824-3829.
Crossref
B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers & J. B. Blumberg. (2008) Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?. JNCI Journal of the National Cancer Institute 100:11, pages 773-783.
Crossref
Jae-Lyun Lee & Yoon-Koo Kang. (2008) Capecitabine in the treatment of advanced gastric cancer. Future Oncology 4:2, pages 179-198.
Crossref
Larry J. Copeland. 2007. Clinical Gynecologic Oncology. Clinical Gynecologic Oncology 313 367 .
Gregory J Welder, Timothy R Wessel, Christopher B Arant, Richard S Schofield & Issam Zineh. (2006) Complementary and Alternative Medicine Use Among Individuals Participating in Research: Implications for Research and Practice. Pharmacotherapy 26:12, pages 1794-1801.
Crossref
Gino Marioni, Rosario Marchese-Ragona, Giuseppe Cartei, Fortunata Marchese & Alberto Staffieri. (2006) Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treatment Reviews 32:7, pages 504-515.
Crossref
Amy S. Clark & Linda T. Vahdat. (2004) Chemotherapy-Induced Palmar-Plantar Erythrodysesthesia Syndrome: Etiology and Emerging Therapies. Supportive Cancer Therapy 1:4, pages 213-218.
Crossref
Jim CassidyJosep TaberneroChris TwelvesRené BrunetCharles ButtsThierry ConroyFilippo DebraudArie FigerJohannes GrossmannNoriaki SawadaPatrick SchöffskiAlberto SobreroEric Van CutsemEduardo Díaz-Rubio. (2004) XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology 22:11, pages 2084-2091.
Crossref
Linda Mileshkin, Yoland Antill & Danny Rischin. 2004. Gynecologic Cancer. Gynecologic Cancer 605 628 .
Peter Gilbar. (2016) Palmar-plantar erythrodysesthesia. Journal of Oncology Pharmacy Practice 9:4, pages 137-150.
Crossref
Manabu Nishikawa, Hidehiko Nagatomi, Bao-Jun Chang, Eisuke Sato & Masayasu Inoue. (2001) Targeting Superoxide Dismutase to Renal Proximal Tubule Cells Inhibits Mitochondrial Injury and Renal Dysfunction Induced by Cisplatin. Archives of Biochemistry and Biophysics 387:1, pages 78-84.
Crossref
Eduardo Nagore, Amelia Insa & Onofre Sanmart??n. (2000) Antineoplastic Therapy???Induced Palmar Plantar Erythrodysesthesia (???Hand-Foot???) Syndrome. American Journal of Clinical Dermatology 1:4, pages 225-234.
Crossref
Alberto Manetta, Krishnansu Tewari & Edward S. Podczaski. (1997) Hexamethylmelamine as a Single Second-Line Agent in Ovarian Cancer: Follow-up Report and Review of the Literature. Gynecologic Oncology 66:1, pages 20-26.
Crossref
Scott Wadler, Beow Yeap, Steven Vogl & Paul Carbone. (1996) Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: Initial and long term results—Eastern Cooperative Oncology Group study E2878. Cancer 77:4, pages 733-742.
Crossref
G.B. Kristensen, M. Baekelandt, I.B. Vergote & C. Trope. (1995) A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma. European Journal of Cancer 31:11, pages 1778-1780.
Crossref
Franco M. Muggia. (1994) Cytoprotection: concepts and challenges. Supportive Care in Cancer 2:6, pages 377-379.
Crossref
S. Kim, S.B. Howell, E. McClay, S. Kirmani, R. Goel, S. Plaxe, P. Braly & A. Bonetti. (1993) Dose intensification of cisplatin chemotherapy through biweekly administration. Annals of Oncology 4:3, pages 221-227.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.